US92852W5013 - Common Stock
We're starting the day with a breakdown of the biggest pre-market stock movers traders will want to watch on Wednesday morning!
Tritium (DCFC) stock is rocketing higher on Tuesday thanks to a couple of pieces of positive news from the EV charging company.
Xpeng (XPEV) stock is slipping on Tuesday after the EV maker cut the price of its cars in China to keep up with competitors.
Mullen Automotive (MULN) stock is falling on Tuesday as investors prepare for an upcoming shareholder meeting on Thursday.
Viveve Medical (VIVE) stock is falling hard on Tuesday after releasing poor results from the company's latest clinical trial.
We're starting off Tuesday with a look at the biggest pre-market stock movers that traders will want to keep an eye on today!
Viveve Medical (VIVE) treatment for female stress urinary incontinence ((SUI)) failed a pivotal trial and the company has decided to seek strategic alternatives and delist from...
Total revenue of $1.8 million in Q2 including sale of 2,850 disposable treatment tips
ENGLEWOOD, CO / ACCESSWIRE / July 28, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and the treatment of stress urinary incontinence (SUI), today announced that it will report its second quarter 2022 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, August 11, 2022. The Company will hold a conference call and webcast at 5:00 PM ET the same day.
ENGLEWOOD, CO / ACCESSWIRE / July 12, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health and the treatment of stress urinary incontinence (SUI), today announced that the Taiwan Intellectual Property Office (TIPO) recently issued Taiwan Patent No. I766557 for Viveve's dual-energy technology. The awarded patent further expands and strengthens Viveve's intellectual property portfolio in one of Asia's key markets.
ENGLEWOOD, CO / ACCESSWIRE / May 17, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's health, today announced that Scott Durbin, chief executive officer, will participate in the H.C. Wainwright Global Investment Conference, May 23 - 26, 2022. Mr. Durbin will deliver the Viveve corporate presentation and meet with investment community members during the hybrid conference. Event: H.C. Wainwright Global
Durbin recognized for second consecutive year for leading development of Viveve's innovative technology for treatment of stress urinary incontinence in women ENGLEWOOD, CO / ACCESSWIRE / May 17, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, announced today that Scott Durbin, the Company's Chief Executive Officer, has been named by Healthcare Technology Report as one of The Top 50
Total revenue of $1.6 million in Q1 including sale of 2,750 consumable treatment tips PURSUIT trial top-line results anticipated at end of 2022 Conference call to be hosted by Company at 5:00 PM ET today ENGLEWOOD, CO / ACCESSWIRE / May 12, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today reported financial results for the quarter ended March 31, 2022, and will provide a
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.